Aramark (ARMK) is set to release its Q4 earnings on Monday, November 17, with analysts forecasting EPS of $0.65 and revenue of $5.16 billion, representing year-over-year growth, despite the company reporting weaker-than-expected Q3 sales. The stock closed down 1.3% at $38.03 on Friday. Ahead of the report, analyst sentiment remains largely positive, with recent actions including an upgrade to Outperform by Baird and a reinstated Buy rating from Citigroup, alongside price target adjustments from UBS and Morgan Stanley.
Aramark (ARMK) is poised to release its fourth-quarter earnings on November 17, with consensus estimates forecasting diluted EPS of $0.65 on $5.16 billion in revenue. These projections indicate a substantial year-over-year improvement from $0.54 EPS and $4.42 billion in the prior-year period, signaling a potential rebound following weaker-than-expected sales reported in Q3. Despite the optimistic Q4 outlook, ARMK shares closed down 1.3% at $38.03 on Friday, suggesting some market apprehension or profit-taking ahead of the announcement. This modest decline could reflect investor caution given the previous quarter's sales performance. Analyst sentiment, however, remains largely constructive, with recent actions including Baird's upgrade to Outperform and a raised price target of $47, alongside Citigroup reinstating a Buy rating with a $48 target. While UBS slightly lowered its price target to $45, it maintained a Buy rating, reinforcing a generally positive view on Aramark's fundamental trajectory.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
